Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598–606.

Article  PubMed  PubMed Central  Google Scholar 

Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.

Article  PubMed  Google Scholar 

Maucort-Boulch D, de Martel C, Franceschi S, Plummer M. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. Int J Cancer. 2018;142(12):2471–7.

Article  CAS  PubMed  Google Scholar 

Wang SH, Yeh SH, Chen PJ. Unique features of hepatitis B virus-related hepatocellular carcinoma in pathogenesis and clinical significance. Cancers (Basel). 2021;13(10):2454.

Article  CAS  PubMed  Google Scholar 

Jiang Y, Han Q, Zhao H, Zhang J. The mechanisms of HBV-induced hepatocellular carcinoma. J Hepatocell Carcinoma. 2021;8:435–50.

Article  PubMed  PubMed Central  Google Scholar 

Deng Y, Li P, Liu W, Pu R, Yang F, Song J, et al. The genetic polymorphism down-regulating HLA-DRB1 enhancer activity facilitates HBV persistence, evolution and hepatocarcinogenesis in the Chinese Han population. J Viral Hepat. 2020;27(11):1150–61.

Article  CAS  PubMed  Google Scholar 

Wu W, Yuan X, Zhang W, Zhou H, Kong X, He Z, et al. Clinical significance of novel biomarkers to predict the natural course of hepatitis B infection. Front Public Health. 2022;10:1037508.

Article  PubMed  PubMed Central  Google Scholar 

Deng Y, Du Y, Zhang Q, Han X, Cao G. Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma. Cancer Lett. 2014;343(2):161–71.

Article  CAS  PubMed  Google Scholar 

Zhang Q, Yin J, Zhang Y, Deng Y, Ji X, Du Y, et al. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus Infections, possibly through interacting with viral mutations. J Virol. 2013;87(22):12176–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie J, Ding Y, Li X, Pu R, Liu W, Li P, et al. Association of ESR1 gene polymorphisms with the susceptibility to hepatitis B virus Infection and the clinical outcomes. J Med Virol. 2023;95(2):e28510.

Article  CAS  PubMed  Google Scholar 

Liu W, Wu J, Yang F, Ma L, Ni C, Hou X, et al. Genetic polymorphisms predisposing the interleukin 6-Induced APOBEC3B-UNG imbalance increase HCC risk via promoting the generation of APOBEC-signature HBV mutations. Clin Cancer Res. 2019;25(18):5525–36.

Article  CAS  PubMed  Google Scholar 

Yeh CT, So M, Ng J, Yang HW, Chang ML, Lai MW, et al. Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology. 2010;52(6):1922–33.

Article  CAS  PubMed  Google Scholar 

Huang Y, Tai AW, Tong S, Lok AS. HBV core promoter mutations promote cellular proliferation through E2F1-mediated upregulation of S-phase kinase-associated protein 2 transcription. J Hepatol. 2013;58(6):1068–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin J, Xie J, Liu S, Zhang H, Han L, Lu W, et al. Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol. 2011;106(1):81–92.

Article  CAS  PubMed  Google Scholar 

Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst. 2009;101(15):1066–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin J, Xie J, Zhang H, Shen Q, Han L, Lu W, et al. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma. J Gastroenterol. 2010;45(10):1063–71.

Article  CAS  PubMed  Google Scholar 

Yin J, Chen X, Li N, Han X, Liu W, Pu R, et al. Compartmentalized evolution of hepatitis B virus contributes differently to the prognosis of hepatocellular carcinoma. Carcinogenesis. 2021;42(3):461–70.

Article  CAS  PubMed  Google Scholar 

Hegde NR, Chevalier MS, Johnson DC. Viral inhibition of MHC class II antigen presentation. Trends Immunol. 2003;24(5):278–85.

Article  CAS  PubMed  Google Scholar 

Cho KJ, Ishido S, Eisenlohr LC, Roche PA. Activation of dendritic cells alters the mechanism of MHC class II antigen presentation to CD4 T cells. J Immunol. 2020;204(6):1621–9.

Article  CAS  PubMed  Google Scholar 

Ji X, Zhang Q, Li B, Du Y, Yin J, Liu W, et al. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. Infect Genet Evol. 2014;28:201–9.

Article  CAS  PubMed  Google Scholar 

Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W, et al. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology. 2011;53(2):422–8.

Article  CAS  PubMed  Google Scholar 

Hu L, Zhai X, Liu J, Chu M, Pan S, Jiang J, et al. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology. 2012;55(5):1426–31.

Article  CAS  PubMed  Google Scholar 

Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009;41(5):591–5.

Article  CAS  PubMed  Google Scholar 

Hu Z, Liu Y, Zhai X, Dai J, Jin G, Wang L, et al. New loci associated with chronic hepatitis B virus infection in Han Chinese. Nat Genet. 2013;45(12):1499–503.

Article  CAS  PubMed  Google Scholar 

Tran A, Kremsdorf D, Capel F, Housset C, Dauguet C, Petit MA, et al. Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV Infection. J Virol. 1991;65(7):3566–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brunetto MR, Giarin MM, Oliveri F, Chiaberge E, Baldi M, Alfarano A, et al. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A. 1991;88(10):4186–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan L, Zhang L, Zhang W, Wu X, Li Y, Yan B, et al. A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations. Hum Mol Genet. 2014;23(8):2210–9.

Article  CAS  PubMed  Google Scholar 

Yucesoy B, Talzhanov Y, Johnson VJ, Wilson NW, Biagini RE, Wang W, et al. Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations. Vaccine. 2013;31(46):5381–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong M, Jung J, Jin HS, Hwang D. Genetic polymorphism of HLA-DRA and alcohol consumption affect hepatitis development in the Korean population. Genes Genomics. 2022;44(9):1109–16.

Article  CAS  PubMed  Google Scholar 

Liao X, Yu L, Liu X, Han C, Yu T, Qin W, et al. Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinoma. Cancer Manag Res. 2018;10:953–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64(1 Suppl):84–S101.

Article  Google Scholar 

Huang YH, Liao SF, Khor SS, Lin YJ, Chen HY, Chang YH, et al. Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank. Aliment Pharmacol Ther. 2020;52(4):682–91.

Article  CAS  PubMed  Google Scholar 

Mai H, Chen J, Chen H, Liu Z, Huang G, Wang J, et al. Fine mapping of the MHC region identifies novel variants associated with HBV-related hepatocellular carcinoma in Han Chinese. J Hepatocell Carcinoma. 2021;8:951–61.

Article  PubMed  PubMed Central  Google Scholar 

Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet. 2013;45(1):72–5.